Literature DB >> 1245283

Circulating antibodies to bovine albumin in ulcerative colitis and Crohn's disease. Characterization of the antibody response.

K R Falchuk, K J Isselbacher.   

Abstract

The presence of antibodies against a dietary protein, bovine serum albumin (BSA), was investigated in the serum of normal subjects and patients with inflammatory bowel disease and celiac disease. Antibodies to BSA were demonstrated in 28 of 30 patients with ulcerative colities (93%), 30 of 35 with Crohn's disease (86%), 5 with untreated celiac disease and in 12 of 28 normal subjects (43%). In patients with inflammatory bowel disease, antibodies to BSA were present in greater amounts in those with severe and moderate disease than in those with mild disease. Moreover, in those patients with high titers of circulating antibody, the serum anti-BSA activity was always associated with IgG and sometimes with IgA. These findings suggest that an increased absorption of antigenic material and stimulation of antibody production may occur in association with intestinal mucosal damage, not only in ulcerative colitis and celiac disease, but also in Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1245283

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  18 in total

1.  Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease.

Authors:  C L Sutton; H Yang; Z Li; J I Rotter; S R Targan; J Braun
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

2.  Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance.

Authors:  M H Giaffer; A Clark; C D Holdsworth
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

3.  Antibody (IgG, IgA, and IgM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease.

Authors:  E Lindberg; K E Magnusson; C Tysk; G Järnerot
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

4.  Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease.

Authors:  H McKenzie; J Main; C R Pennington; D Parratt
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

5.  Soya protein antibodies in man: their occurrence and possible relevance in coeliac disease.

Authors:  M R Haeney; B J Goodwin; M E Barratt; N Mike; P Asquith
Journal:  J Clin Pathol       Date:  1982-03       Impact factor: 3.411

6.  Immune status in Crohn's disease. 3. Peripheral blood B lymphocytes, enumerated by means of F(ab)2-antibody fragments, Null and T lymphocytes.

Authors:  I O Auer; S Götz; E Ziemer; H Malchow; H Ehms
Journal:  Gut       Date:  1979-04       Impact factor: 23.059

7.  Macroamylasemia associated with ulcerative colitis.

Authors:  Y Fujimura; C Nishishita; J Uchida; M Iida
Journal:  J Mol Med (Berl)       Date:  1995-02       Impact factor: 4.599

8.  The humoral immune system in inflammatory bowel disease. II. Immunologlobulin levels.

Authors:  H J Hodgson; D P Jewell
Journal:  Am J Dig Dis       Date:  1978-02

9.  Antibodies to maize in patients with Crohn's disease, ulcerative colitis and coeliac disease.

Authors:  I W Davidson; R S Lloyd; P J Whorwell; R Wright
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

10.  Class II major histocompatibility complex antigen expression on peripheral blood monocytes in patients with inflammatory bowel disease.

Authors:  K R Gardiner; A D Crockard; M I Halliday; B J Rowlands
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.